Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aspirin resistance: definition, mechanisms and clinical read-outs.

× No keyword cloud information.

42 in total

1. Aspirin resistance.

Authors: Graeme J Hankey; John W Eikelboom
Journal: BMJ Date: 2004-02-28

Review 2. Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2).

Authors: Shehzad Sami; James T Willerson
Journal: Tex Heart Inst J Date: 2010

3. NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities.

Authors: Heng-Lan Kuo; Jin-Cherng Lien; Ching-Hu Chung; Chien-Hsin Chang; Shyh-Chyi Lo; I-Chun Tsai; Hui-Chin Peng; Sheng-Chu Kuo; Tur-Fu Huang
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2010-03-27 Impact factor: 3.000

4. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.

Authors: Cezary Watala; Justyna Pluta; Jacek Golanski; Marcin Rozalski; Malgorzata Czyz; Zygmunt Trojanowski; Józef Drzewoski
Journal: J Mol Med (Berl) Date: 2004-11-10 Impact factor: 4.599

5. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.

Authors: Gergely Feher; Katalin Koltai; Elod Papp; Balint Alkonyi; Alexander Solyom; Peter Kenyeres; Gabor Kesmarky; Laszlo Czopf; Kalman Toth
Journal: Drugs Aging Date: 2006 Impact factor: 3.923

6. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.

Authors: Oyku Gulmez; Aylin Yildirir; Gamze Kaynar; Didem Konas; Alp Aydinalp; Cagatay Ertan; Bulent Ozin; Haldun Muderrisoglu
Journal: J Thromb Thrombolysis Date: 2007-06-16 Impact factor: 2.300

Aspirin resistance: definition, mechanisms and clinical read-outs.

1. Aspirin resistance.

Review 2. Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2).

3. NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities.

4. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin.

5. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.

6. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.

Review 7. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis.

8. Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention.

9. Role of TGF-beta1 and MAP kinases in the antiproliferative effect of aspirin in human vascular smooth muscle cells.

10. Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease.